These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 3840335)
21. [Fatal arrhythmia following administration of suxamethonium to a postpartum women who subsequently was found to have dystrophia myotonica]. Wintzen AR Ned Tijdschr Geneeskd; 1996 Aug; 140(35):1783. PubMed ID: 8927137 [No Abstract] [Full Text] [Related]
28. Comparison of the neuromuscular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia. Caldwell JE; Heier T; Kitts JB; Lynam DP; Fahey MR; Miller RD Br J Anaesth; 1989 Oct; 63(4):393-9. PubMed ID: 2530998 [TBL] [Abstract][Full Text] [Related]
29. Transient cross-resistance to neuromuscular blocking agents in a patient with tetanus. Chiu JW; Tsou CH; Liou JT; Hsin ST; Luk HN Anesthesiology; 2003 Feb; 98(2):579-81. PubMed ID: 12552222 [No Abstract] [Full Text] [Related]
30. Importance of the level of paralysis recovery for a rapid antagonism of atracurium neuromuscular blockade with moderate doses of edrophonium. Hennart D; d'Hollander A; Plasman C; De Jonckheere M Anesthesiology; 1986 Mar; 64(3):384-7. PubMed ID: 3754099 [No Abstract] [Full Text] [Related]
31. Mivacurium in an obese patient with myotonic dystrophy--a case report. Yazigi A; el Hage C; Richa F; Antakly MC Middle East J Anaesthesiol; 1997 Jun; 14(2):77-82. PubMed ID: 9258883 [TBL] [Abstract][Full Text] [Related]
32. Comparison of atracurium and alcuronium in day-case gynaecological surgery. Collins KM; Plantevin OM; Docherty PW Anaesthesia; 1984 Nov; 39(11):1130-4. PubMed ID: 6239561 [TBL] [Abstract][Full Text] [Related]
34. Induction of anaesthesia with propofol ('Diprivan') or thiopentone and interactions with suxamethonium, atracurium and vecuronium. Nightingale P; Petts NV; Healy TE; Kay B; McGuinness K Postgrad Med J; 1985; 61 Suppl 3():31-4. PubMed ID: 2865719 [TBL] [Abstract][Full Text] [Related]
35. Atracurium for intubation in man. A clinical and electromyographic study. Stirt JA; Katz RL; Schehl DL; Lee C Anaesthesia; 1984 Dec; 39(12):1214-21. PubMed ID: 6097137 [TBL] [Abstract][Full Text] [Related]
36. The pharmacology of atracurium: a new competitive neuromuscular blocking agent. Hughes R; Chapple DJ Br J Anaesth; 1981 Jan; 53(1):31-44. PubMed ID: 6161627 [TBL] [Abstract][Full Text] [Related]
37. Circulatory effects of atracurium in patients with cardiovascular disease. Moyers JR; Carter JG; Fehr BL; Lineberry CC; Sokoll MD; Shimosato S Br J Anaesth; 1986; 58 Suppl 1():83S-88S. PubMed ID: 3754759 [TBL] [Abstract][Full Text] [Related]
38. Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium. Varin F; Ducharme J; Théorêt Y; Besner JG; Bevan DR; Donati F Clin Pharmacol Ther; 1990 Jul; 48(1):18-25. PubMed ID: 2369806 [TBL] [Abstract][Full Text] [Related]
40. Influences of cisatracurium besylate and vecuronium bromide on muscle relaxant effects and electromyography of tracheal intubation under general anesthesia. Yu DJ; Gao HY Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1974-1979. PubMed ID: 28485777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]